Association between rs4938723 functional polymorphism in the promoter region of miR-34b/c gene and cancer risk
- PMID: 25475831
- DOI: 10.1016/j.clinre.2014.10.007
Association between rs4938723 functional polymorphism in the promoter region of miR-34b/c gene and cancer risk
Abstract
Genetic polymorphism of miR-34b/c gene is a candidate factor for attributing predisposition to carcinoma. However, results of mounting studies, concerning association of miR-34b/c gene rs4938723 with risk of cancer, present contradictory results. Therefore, a meta-analysis was performed to systematically assessment the possible association between them. The overall results of meta-analysis indicate a significant association was only observed between rs4938723 and cancer risk in genotype model (P(h)=0.203, OR=1.09, 95% CI=1.01-1.70 for CT vs. TT). After stratifying by ethnicity and cancer type, genotype CT of rs4938723 was significantly association with an increased cancer risk in Asian population (P(h)=0.187, OR=1.10, 95%CI=1.01-1.20), allele C and genotype CT were significantly positive associated with hepatocellular cancer (P(h)=0.113, OR=1.11, 95%CI=1.01-1.23 for C vs. T; P(h)=0.121, OR=1.19, 95%CI=1.03-1.37 for CT vs. TT), but rs4938723 was negative associated with risk of colorectal cancer (P(h)=0.342, OR=0.66, 95%CI=0.47-0.92 for CC vs. TT; P(h)=0.519, OR=0.67, 95%CI=0.49-0.93 for CC vs. CT/TT; P(h)=0.443, OR=0.71, 95%CI=0.51-0.99 for CC/TT vs. CT). These findings suggested that rs4938723 was a susceptible locus only for hepatocellular cancer and colorectal cancer.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Similar articles
-
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.Mutagenesis. 2014 Mar;29(2):149-54. doi: 10.1093/mutage/geu001. Epub 2014 Feb 6. Mutagenesis. 2014. PMID: 24503183
-
Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.Arch Med Res. 2019 Feb;50(2):55-62. doi: 10.1016/j.arcmed.2019.05.008. Epub 2019 Jun 12. Arch Med Res. 2019. PMID: 31349954
-
Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.Tumour Biol. 2016 May;37(5):6267-73. doi: 10.1007/s13277-015-4467-y. Epub 2015 Nov 30. Tumour Biol. 2016. PMID: 26619844
-
The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.OMICS. 2013 Apr;17(4):200-14. doi: 10.1089/omi.2012.0089. OMICS. 2013. PMID: 23574339 Free PMC article. Review.
-
Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.Tumour Biol. 2013 Feb;34(1):223-30. doi: 10.1007/s13277-012-0542-9. Epub 2012 Oct 4. Tumour Biol. 2013. PMID: 23055196 Review.
Cited by
-
Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.Front Oncol. 2022 Aug 9;12:960269. doi: 10.3389/fonc.2022.960269. eCollection 2022. Front Oncol. 2022. PMID: 36016604 Free PMC article.
-
Functional polymorphisms in the promoter region of miR-17-92 cluster are associated with a decreased risk of colorectal cancer.Oncotarget. 2017 Jul 31;8(47):82531-82540. doi: 10.18632/oncotarget.19753. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137282 Free PMC article.
-
An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.Oncotarget. 2017 Apr 25;8(17):28888-28896. doi: 10.18632/oncotarget.16322. Oncotarget. 2017. PMID: 28415817 Free PMC article.
-
Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.Biomed Rep. 2016 Jul;5(1):125-129. doi: 10.3892/br.2016.690. Epub 2016 May 23. Biomed Rep. 2016. PMID: 27347415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
